Page last updated: 2024-11-03

risperidone and Carcinoma, Papillary

risperidone has been researched along with Carcinoma, Papillary in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" The hyperprolactinemia was due to prolonged treatment with the anti-dopaminergic neuroleptic risperidone in Case 1, and chronic renal failure in Case 2."3.74Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia. ( Bruno, R; Calcinaro, F; Colandrea, M; Durante, C; Filetti, S; Maranghi, M; Montesano, T; Puxeddu, E; Ronga, G; Russo, D; Travascio, L, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ronga, G1
Bruno, R1
Puxeddu, E1
Calcinaro, F1
Montesano, T1
Travascio, L1
Colandrea, M1
Durante, C1
Maranghi, M1
Filetti, S1
Russo, D1

Other Studies

1 other study available for risperidone and Carcinoma, Papillary

ArticleYear
Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia.
    Thyroid : official journal of the American Thyroid Association, 2007, Volume: 17, Issue:4

    Topics: Breast; Carcinoma, Papillary; Female; Humans; Hyperprolactinemia; Iodine Radioisotopes; Kidney Failu

2007